ProQR Therapeutics NV
For the period ended Dec 31, 2024. Filed Mar 13, 2025.
View on SEC.govAbout this filing
The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.
FY2024 · Filed Mar 13, 2025
PRQR$1.35+1.5%Stored close · as of Nov 6, 2026
Contents
B. Significant Changes
There have been no significant changes since the date of the annual financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.